LCKYF yields 984.74% · PFE yields 6.13%● Live data
📍 LCKYF pulled ahead of the other in Year 1
Combined, LCKYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LCKYF + PFE for your $10,000?
Golden Sky Minerals Corp. operates as a mineral exploration company in Canada. The company engages in acquisition, development, exploration, and evaluation of mineral properties. It primarily explores for gold deposits. The company holds 100% interest in the Lucky Strike property located in Yukon, Canada; the BRC property located in Yukon, Canada; and the Gold Source property located in southwest of Dawson, Yukon. It also holds 100% interest in the Hot Spot Property located in south of Dawson, Yukon; the King's Ransom Property; the Bull's Eye Property located in south of Dawson, Yukon; the Rayfield Property located in British Columbia, Canada; and the Eagle Mountain gold property that covers an area of approximately 10,000 hectares located in the Cassiar District of British Columbia. The company was formerly known as Luckystrike Resources Ltd. and changed its name to Golden Sky Minerals Corp. in February 2020. Golden Sky Minerals Corp. was incorporated in 2018 and is headquartered in Vancouver, Canada.
Full LCKYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.